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 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.Figure 1. Biologically active thiazolo ring-fused 2-pyridones with peptidomimetic
backbones (highlighted).2-Pyridones are privileged structures in medicinal chemistry,1
and many biologically active ring-fused 2-pyridones exist, for
example, the natural product derived anti-cancer drug, topotecan,2
and the acetylcholinesterase inhibitor, huperzine A.3 The ring-
fused 2-pyridones 1 and 2 (Fig. 1) belong to a class of compounds
designed as peptidomimetics.4 This type of thiazolo ring-fused 2-
pyridone has various biological effects depending on their substi-
tution pattern, for example, as antibacterials—targeting bacterial
virulence,5,6 and as modulators of the ﬁbrillation of amyloid pro-
teins, such as Alzheimer b-peptides7 and the Parkinson’s associated
a-synuclein.8 Previous synthetic efforts to improve, or to alter the
biological activity of these compounds have focused on variation of
the substituents9 as well as changes of the central fragment it-
self.10,11 Here, we report the synthesis of a series of central frag-
ment analogs of compounds 1 and 2 using a strategy inspired by
the concepts of diversity-oriented synthesis (DOS).12,13
The aim with DOS is to prepare compound collections with
widely diverse central fragments to ﬁnd biologically active sub-
stances without having a pre-determined target.14 Considering
the diverse biological activities of the thiazolo ring-fused 2-pyri-
dones, we believe that further exploration of the chemical space
around this class will generate many new compounds that are ac-
tive in a variety of biological assays. In efforts toward this goal, we
have developed a strategy involving directed diversity-oriented
synthesis, where the produced compounds are relatively close to
compounds 1 and 2 in the chemical space, but still considerablyAlmqvist).
Y-NC-ND license.more varied than what is usually achieved by substituent variation.
Inspired by the use of a 2-ﬂuorobenzene sulfonyl chloride as a two-
sited electrophile in the preparation of a DOS-library,15 compound
3 was prepared in analogy with previously prepared com-
pounds,16,17 and then formylated18 to give compound 4, which
contains two different electrophilic sites (Scheme 1). This key
starting material allowed the synthesis of compounds with large
variations of the left-hand side of the peptidomimetic 2-pyridone
by orthogonally reacting the two electrophilic groups to form var-
ious ring-structures.
To start with, two new heteroaromatic scaffolds were prepared.
Heteroaromatics are often easily functionalized and give rigid com-
pounds, which can be beneﬁcial for biological activity.19 Ring-fused
pyrroles have been prepared from other compounds with two elec-
trophilic sites,20,21 and reaction of 4 with primary amines under
basic conditions gave the pyrroles 5 and 6 (Scheme 2A).
The corresponding ring-fused thiophene 7 was obtained by
reaction with potassium thioacetate followed by cleavage of the
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Scheme 1. Preparation of a 2-pyridone with two electrophilic sites.
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Scheme 5. Synthesis of eight-membered rings and a pyrrolidone ring-fused
compound.
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Scheme 3. Improved syntheses of naphthyridones and naphthyridonium salts.
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Scheme 4. Synthesis of seven-membered carbamates.
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Scheme 2. Ring-fused ﬁve-membered heteroaromatics.
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The use of sodium sulﬁde instead of potassium thioacetate gave
signiﬁcant amounts of a dimeric compound (according to LC–MS).
We previously described a three-component reaction that pro-
duced dihydronaphthyridones from methyl and formyl substituted
2-pyridones such as 8. Subsequent oxidation with air, or more gen-
erally, with chloranil, gave naphthyridones and naphthyridonium
salts (Scheme 3A).22 Compound 4 participated in similar reactions
when reacted with aldehydes and amines under mildly acidic con-
ditions (Scheme 3B). The naphthyridone 9 and the naphthyridoni-
um salt 10 were formed without the need of an extra oxidation
step, thus providing a more straightforward route to these types
of compounds.
Althoughnewheteroaromatic scaffolds are valuable inmedicinal
chemistry,23 compounds with a higher proportion of sp3-carbons
and stereochemical complexity often interactmore speciﬁcallywith
proteins.24 A higher proportion of saturated carbons also decreasesstructural planarity, which typically improves aqueous solubility.25
By preparing medium-sized rings with saturated carbons, less pla-
nar compounds with restricted ﬂexibility were created. To synthe-
size the seven-membered carbamates 14 and 15, compound 4 was
reduced to the alcohol 11, reacted with an amine, and then ring-
closed with triphosgene (Cl3COCOOCCl3) (Scheme 4).
Two compounds containing eight-membered rings were syn-
thesized by nucleophilic substitution of the chloride followed by
reductive amination of the aldehyde (Scheme 5). Thus, Boc-pro-
tected cysteine methyl ester was reacted with 4 and then deprotec-
ted with triﬂuoroacetic acid. Ring-closure to compound 16 was
accomplished with sodium borohydride in methanol. The use of
non-protected cysteine gave several by-products. Triazole 17 was
prepared by displacement of the chloride with sodium azide fol-
lowed by reductive amination with N-methyl propargylamine. A
thermal intramolecular Huisgen cyclization26,27 then gave the
ring-closed product 17. During the ﬁrst step in the synthesis of
17, small amounts of the ring-fused pyrrolidone 18 were formed.
This type of transformation usually requires acidic conditions
and is then regarded an intramolecular Schmidt rearrangement,28
but in our case acid did not promote the formation of 18. However,
it was found that slightly elevated temperatures and longer reac-
tion times increased the amount of this product and allowed its
isolation in 62% yield.
We planned to prepare a nine-membered ring system by ring-
closing metathesis.29 To introduce the alkenes for the metathesis,
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Scheme 6. Hosomi-Sakurai allylation of 4.
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Scheme 7. Ring-closing metathesis provided compound 21.
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Scheme 8. Lactonization into a 10-membered ring.
6024 M. Sellstedt et al. / Tetrahedron Letters 53 (2012) 6022–6024compound 4 was ﬁrst allylated with allyltrimethylsilane.30 Differ-
ent conditions for the allylation were evaluated, and the best re-
sults were accomplished in 1,4-dioxane with BF3Et2O as the acid
(Scheme 6). After puriﬁcation, a 3.7:1 diastereomeric mixture of
19was obtained in 73% yield (2.5:1 dr before puriﬁcation). A lower
diastereomeric ratio (1.8:1) was obtained in dichloromethane, and
with SnCl4 as the Lewis acid the diastereoselectivity inverted to
give a 1:2.2 mixture.
Next, compound 19 was reacted with allylamine to introduce
the second alkene needed for the metathesis. The resulting amine
20 was then N-acylated, and the ring-closing metathesis was real-
ized by the use of Grubbs’ second generation catalyst31 in toluene
(20 mM) to give 21 in 72% yield (Scheme 7).
For the 10-membered case, we considered a lactone ring-clo-
sure. Although medium-sized lactones are often difﬁcult to prepare
because of competing formation of dimeric species,32 substrates
with rigidifying elements such as Z-double bonds can give efﬁcient
reactions.33 The 10-membered lactone 23 was prepared from the
alcohol 11, which was ﬁrst reacted with the allyl ester of N-
methyl-c-aminobutyric acid to give 22. This product was then sub-
jected to palladium-catalyzed deallylation, followed by lactoniza-
tion to give 23 using PyBOP as the coupling reagent34 (Scheme
8). The ring-closure proceeded well using modest dilute conditions
(50 mM) without the need for slow addition of the substrate.In conclusion, we have applied a strategy of directed diversity-
oriented synthesis to prepare a series of 5- to 10-membered ring-
fused structural peptidomimetics starting from a chloromethyl and
formylated compound. This type of two-sited electrophile can
potentially be used to construct a wide range of ring-fused hetero-
cycles. The compounds produced here are diverse analogs of bio-
logically active 2-pyridones that will be evaluated in a variety of
biological assays in the near future.
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